Valeant to buy PharmaSwiss
Expat Financial & Investment News Update
Robert Harris of Forth Capital presents a market rundown and says that the effect of Egyptian unrest is starting to wane. A leading indicator for economic health is the rate of mergers and aquisitions. Harris says that M&A activiity is taking off in the U.S. including a deal in which Valeant Pharmaceuticals has agreed to buy PharmaSwiss.